Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
$148M funding (Series D 2024 TeamViewer); $21M revenue Nov 2024; 65 employees; Nike/Sony/Nissan/Google customers; NVIDIA/Microsoft partnerships 2024; manufacturing analytics leader
Sight Machine is a manufacturing analytics platform that uses AI and machine learning to optimize production operations and improve quality across discrete and process manufacturing. The company serves global manufacturers in automotive, food and beverage, pharmaceuticals, and industrial sectors with real-time visibility, predictive analytics, and actionable insights. Sight Machine creates value by connecting disparate data sources, applying advanced analytics to identify production inefficiencies, and enabling data-driven decision-making that reduces downtime, improves yield, and accelerates time to market.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.